Sonoma Pharmaceuticals Overview
- Founded
- 1999
- Status
- Public
- Employees
- 300
- Stock Symbol
- SNOA
- Investments
- 1
- Share Price
- $8.80
- (As of Thursday Closing)
Sonoma Pharmaceuticals General Information
Description
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing and commercializing differentiated therapies to patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes and others. The company derives revenue from the sale of products in the United States, Latin America, Europe and other countries.
Contact Information
Website
Formerly Known As
Micromed Laboratories, Oculus Innovative Sciences
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Stock Exchange
NAS
Primary Office
- 1129 North Mcdowell Boulevard
- Petaluma, CA 94954
- United States
+1 (707) 000-0000
Sonoma Pharmaceuticals Stock Performance
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $8.80 | $9.80 | $3.33 - $19.60 | $17.3M | 1.97M | 1.09M | -$1.99 |
Sonoma Pharmaceuticals Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2020 | FY 2020 31-Mar-2020 | FY 2019 31-Mar-2019 | FY 2018 31-Mar-2018 |
|---|---|---|---|---|
| EV | 10,027 | 6,081 | 4,963 | 14,459 |
| Revenue | 21,479 | 18,936 | 18,970 | 16,658 |
| EBITDA | (3,214) | (2,547) | (11,044) | (14,006) |
| Net Income | (2,668) | (2,946) | (11,798) | (14,328) |
| Total Assets | 18,652 | 14,561 | 14,448 | 19,206 |
| Total Debt | 1,930 | 1,478 | 475 | 553 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Sonoma Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Sonoma Pharmaceuticals‘s full profile, request access.
Request a free trialSonoma Pharmaceuticals Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identi
Surgical Devices
Petaluma, CA
300
As of 2020
00000
000
0000-00-00
00000000
00000
000000
sequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla
00000000 0000000
Marietta, GA
000
As of 0000
00000
000000000
00000
00000000
aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea com
00000000 0000000
Lewisville, TX
0000
As of 0000
00000000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialSonoma Pharmaceuticals Competitors (6)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Mimedx | Corporation | Marietta, GA | 000 | 00000 | 000000000 | 00000 |
| 00000000 000000000 | Formerly PE-Backed | Lewisville, TX | 0000 | 00000000 | ||
| 00000000 | Formerly VC-backed | San Diego, CA | 0000 | 00000 | 000000 - 000 | 00000 |
| 000 | Formerly PE-Backed | Leesburg, VA | 000 | 00000 | 000000&0 | 00000 |
| 000000 0000000 | Formerly VC-backed | Audubon, PA | 0000 | 00000 | 00000000000 | 00000 |
Sonoma Pharmaceuticals Executive Team (16)
Sonoma Pharmaceuticals Board Members (11)
| Name | Representing | Role | Since |
|---|---|---|---|
| Edward Brown | Self | Board Member | 000 0000 |
| Greg French | Self | Board Member | 000 0000 |
| Jay Birnbaum Ph.D | Self | Board Member | 000 0000 |
| Jerry McLaughlin | Self | Board Member | 000 0000 |
| Philippe Weigerstorfer | Sonoma Pharmaceuticals | Board Member | 000 0000 |
Sonoma Pharmaceuticals Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialSonoma Pharmaceuticals Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0.0. 000000000 000 | 01-Jan-2015 | 000000000 00000 00 | Buildings and Property |